A Phase I Trial of Lometrexol Sodium and Paclitaxel Adminsitered Intravenously Every 21 Days in Conjunction With Oral Folic Acid in Patients With Solid Tumors.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lometrexol (Primary) ; Paclitaxel (Primary) ; Folic acid
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 17 Sep 2013 Biomarkers information updated
- 27 Sep 2005 New trial record.